• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Gilead Sciences

Gilead Sciences

Gilead Sciences Inc GILD 3 Star

Last Price$104.83Day Change (%)0.62%
Open Price$104.33Day Change ($)0.65
Day Range103.73–106.2752-Week Range63.50–116.83

As of Fri 01/30/2015 08:06 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

    Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

  2. MARKET SNAPSHOT: Gasoline 'Tax Cut' In Focus On Energy, Consumer-based Earnings

    MARKET SNAPSHOT: Gasoline 'Tax Cut' In Focus On Energy, Consumer-based Earnings

  3. UPDATE: Gasoline 'tax cut' in focus on energy, consumer-based earnings

    UPDATE: Gasoline 'tax cut' in focus on energy, consumer-based earnings

  4. EnvisionRx and Gilead Sciences Sign Exclusive Agreement to Help in the Fight Against Hepatitis C

    EnvisionRx and Gilead Sciences Sign Exclusive Agreement to Help in the Fight Against Hepatitis C

  5. Gilead , CVS strike deal on Hepatitis C drugs

    Gilead , CVS strike deal on Hepatitis C drugs

  6. Gilead to buy liver disease treatment from Germany's Phenex

    Gilead to buy liver disease treatment from Germany's Phenex

  7. Gilead Sciences Carving Out a Wider Moat

    StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.

  8. AbbVie Predicts Sharp Increase in Earnings

    AbbVie Predicts Sharp Increase in Earnings

  9. UPDATE: Are consumers getting gouged on health care?

    UPDATE: Are consumers getting gouged on health care?

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.